Cargando…
P678: EARLY WARNING RESPONSES IN CML PATIENTS: A REAL-LIFE TURIN EXPERIENCE
Autores principales: | Giai, Valentina, Bisio, Matteo, Rosso, Tiziana, Urbino, Irene, Frairia, Chiara, Olivi, Matteo, Lanzarone, Giuseppe, D’agostino, Mattia, Beggiato, Eloise, D’ ardia, Stefano, Audisio, Ernesta, Cerrano, Marco, Ferrero, Dario, Pregno, Patrizia, Freilone, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428925/ http://dx.doi.org/10.1097/01.HS9.0000969616.68483.49 |
Ejemplares similares
-
PB2057: THE COMBINATION OF ANTI-COMPLEMENT THERAPY AND CYCLOSPORINE +/- ELTROMBOPAG IN PNH IS EFFECTIVE AND SAFE: A REAL-LIFE OBSERVATIONAL STUDY.
por: Catania, Federica, et al.
Publicado: (2023) -
Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors
por: Boscaro, Eleonora, et al.
Publicado: (2023) -
Evolving Therapeutic Approaches for Older Patients with Acute Myeloid Leukemia in 2021
por: Urbino, Irene, et al.
Publicado: (2021) -
Levofloxacin Prophylaxis Versus no Prophylaxis in Acute Myeloid Leukemia During Post-Induction Aplasia: a Single Center Study
por: Urbino, Irene, et al.
Publicado: (2023) -
PB1864: IMPROVED LONG-TERM SURVIVAL OF ELDERLY ADULTS WITH AML RECEIVING INTENSIVE INDUCTION THERAPY FOLLOWED BY EITHER ALLOGENEIC STEM CELL TRANSPLANT OR MAINTENANCE DIFFERENTIATIVE THERAPY
por: DI Biase, Federica, et al.
Publicado: (2023)